2023 May 30, 2023 ERS introduces Wave3000, a State-of-the-Art Warpage Metrology Tool for Advanced Packaging Wafers May 29, 2023 Abiogen Pharma Completes the Acquisition of EffRx May 22, 2023 Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference May 21, 2023 Pieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference May 04, 2023 Pieris Pharmaceuticals Announces Successful Completion of Safety Review for 10 mg Dose of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) May 02, 2023 MEMO THERAPEUTICS AG RECEIVES FDA FAST TRACK DESIGNATION FOR ANTIBKV AS TREATMENT OF BKV INFECTION IN RENAL TRANSPLANT PATIENTS April 17, 2023 Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alfa (PRS-343) At 2023 AACR Annual Meeting February 27, 2023 Lotus 1, Microcontroller (MCU) for home appliances designed by Cortus is available January 24, 2023 Memo Therapeutics AG Announces Positive Phase I Data with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients January 10, 2023 Pieris Pharmaceuticals Announces $5 Million Milestone from Seagen for Initiation of Phase 1 Trial of CD228 x 4-1BB Bispecific Molecule (Mabcalin SGN-BB228 (PRS-346)
